Menu
Subscribe to our Email Alerts
About Us
Island at a glance
Board
Key Management
Scientific Advisory Board
Collaborations
Science
About ISLA-101
Scientific Publications
Drug repurposing and benefits
Investor Centre
Investor Welcome
Clinical programme
ASX Announcements
Financial Reports
Share Price Information
Shareholder Services
Investor Fact Sheet
Corporate Governance
Corporate Directory
International Investors
Research Coverage
AGM
Media
News
Presentations
Contact
Contact Us
Subscribe for Email Alerts
Investor Centre
Investor Centre
>
ASX Announcements
Investor Welcome
Clinical programme
ASX Announcements
Financial Reports
Share Price Information
Shareholder Services
Investor Fact Sheet
Corporate Governance
Corporate Directory
International Investors
Research Coverage
AGM
ASX Announcements
Filter by Year:
2023
2022
2021
7-Feb-2023
Change in substantial holding
1-Feb-2023
ILA receives additional FDA feedback on IND for ISLA 101
30-Jan-2023
Quarterly Activity Report & Appendix 4C
20-Jan-2023
Island receives FDA feedback on Phase 2a clinical study
Previous
1
2
.png){kind=logo}
